← IndicationsOpen filtered programs
Landscape
Vestibular Disorders
Vestibular Disorders has 3 tracked records across 2 named organizations, including 0 strong-evidence records and 1 active programs. Records with caveats and trial-derived candidates remain visible for deeper review.
3
Pipeline Records
strong evidence + caveats + candidates
0
Strong Evidence
3 checked records with caveats
1
Active Programs
currently active
0
Marketed / Approved
commercial or approved
2
Organizations
companies, sponsors, and institutions
Competitive Density
6/100
organization breadth + program volume
Pipeline Velocity
33/100
active and late-stage share
Evidence Coverage
0/100
share strong evidence
Completion Signal
33/100
late-stage, approved, or marketed
Attrition Rate
0/100
share discontinued
Concentration
67/100
top-organization share
Programs by Stage
Phase 41 · 33%
Not applicable2 · 67%
Trial / Program Status
Active1 · 33%
Completed1 · 33%
Unknown1 · 33%
Modality Breakdown
Small Molecule1 · 33%
Small Molecule/Acupoint Injection1 · 33%
Steroid/Anti-inflammatory1 · 33%
Program Types
Therapeutic3 · 100%
Top Organizations
Institution-led study2 · 67%
Institution-led study cluster1 · 33%
Population Tags
adult3 · 100%
meniere-disease1 · 33%
pediatric1 · 33%
study-cluster1 · 33%
sudden-hearing-loss1 · 33%
vertigo1 · 33%
Strong-Evidence Programs
0 recordsNo strong-evidence records yet for this indication.
Checked Records With Caveats
3 recordsHebei gastrodin acupoint injection SNHL vertigo studyStatus caveat
Sponsor / Institution: Institution-led study · Not applicable · Completed
Small Molecule/Acupoint InjectionNot applicableCompleted88% confidence
Oral versus intratympanic glucocorticoid ISSNHL vestibular prognosis studyStatus caveat
Sponsor / Institution: Institution-led study · Not applicable · Unknown
Steroid/Anti-inflammatoryNot applicableUnknown84% confidence
Montelukast Hearing and Vestibular Study ClusterStatus caveat
Sponsor / Institution: Institution-led study cluster · Phase 4 · Active
Small MoleculePhase 4Active78% confidence